Anticancer Activity Study of Modified Artocarpin Compound from Pudau Plant (Artocarpus kemando Miq.)

Acetic Anhydride Artocarpin Leukemia P-388 Cells Modification.

Authors

  • Tati Suhartati
    tati.suhartati@fmipa.unila.ac.id
    Department of Chemistry, Faculty of Mathematics and Natural Sciences, University of Lampung, Lampung 35145,, Indonesia https://orcid.org/0000-0002-9398-1965
  • Khalimatus Sa'diah Department of Chemistry, Faculty of Mathematics and Natural Sciences, University of Lampung, Lampung 35145,, Indonesia
  • Yandri Yandri Department of Chemistry, Faculty of Mathematics and Natural Sciences, University of Lampung, Lampung 35145,, Indonesia
  • Sutopo Hadi Department of Chemistry, Faculty of Mathematics and Natural Sciences, University of Lampung, Lampung 35145,, Indonesia
Vol. 7 No. 3 (2023): June
Research Articles

Downloads

This research is a continuation of the successful isolation of artocarpin from the root of Artocarpus kemando Miq reported in our previous study. In the previous study, the artocarpin was characterized with UV-Vis and FTIR techniques. In this follow-up investigation, the artocarpin was subjected to a transesterification reaction using acetic anhydride and pyridine as catalysts, and the product of the reaction was specified as compound 1. The compound 1 was further characterized with different techniques to gain more complete data and then tested for anticancer activity test against P-388 murine leukemia cells. Characterizations of the compound 1 using 1H-NMR and 13C-NMR techniques suggest that the modification reaction resulted in the conversion of the -OH groups at C2' and 4' at the artocarpin molecule to -OOCH3, and based on the MS analysis, the compound was proposed to have the molecular formula of C30H32O8. Another important feature of compound 1 that should be noted is the significant improvement in stability compared to the unmodified artocarpin. Anticancer activity tests against P-388 murine leukemia cells revealed that compound 1 has an IC50of 2.35 µg/mL, confirming that the compound is categorized as an active anticancer agent and suggesting that the compound has promising potential that deserves further investigations.

 

Doi: 10.28991/ESJ-2023-07-03-05

Full Text: PDF